Collaboration is a key area of proven scientific discovery at Mayo Clinic, and with an international research team led by investigators from the ...
In a recently published article in Hemotology, Center for Individualized Medicine faculty George Vasmatzis, Ph.D., co-authored a study in high resolution mate-pair sequencing. With the use of high resolution mate-pair sequencing (HRMPS) in 15 patients with primary myelofibrosis (PMF): eight with normal karyotype and seven with PMF-characteristic cytogenetic abnormalities, including der(6)t(1;6)(q21–23;p21.3) (n = 4), der(7)t(1;7)(q10;p10) (n = 2), del(20)(q11.2q13.3) (n = 3), and complex karyotype (n = 1).
The Breast Cancer Genome-Guided Therapy (BEAUTY) study is designed to help researchers better understand why standard chemotherapy eradicates breast cancer in some women but fails in others. The long-term goal is to enable individualized treatment for each woman with breast cancer by using the genetic information found in blood samples and tumor biopsies to predict the most effective therapies. Dr. Judy Boughey and Dr. Matthew Goetz joined the Medical Edge radio program (now called Mayo Radio) last September of 2012 to discuss the BEAUTY Project. You can listen to the full program after the break.
Hello! I’m Tammy McAllister, Operations Manager in the Center for Individualized Medicine at Mayo Clinic. As administrative partner to Dr. Kostas Lazaridis, Enterprise Director of the Individualized Medicine (IM) Clinic, our roles include overseeing the management and expansion of the newly formed IM Clinic. This is a really exciting time in healthcare! Discoveries made through the Human Genome Project are rapidly progressing and, at the same time, the cost of genomic testing is declining making it practical to use these new, powerful tools for patient care. At Mayo, our new IM Clinic focuses on using these new advances in DNA sequencing to benefit our patients--to help diagnose, treat, predict or prevent disease. Because of the complex nature and enormous volume of the data generated by DNA sequencing, we want to help shepherd the beginning of this translation process at Mayo Clinic. The key is to show that using these new tests is effective and efficient because they use the patients’ unique DNA to help tailor, or individualize, treatment specific to their own version of their disease--ultimately saving the patients time, expense and the pain of failed other treatments.
Jen McCormick, Ph.D., director of the Bioethics Program for the Center for Individualized Medicine at Mayo Clinic outlines the goal of Bioethics to ...
http://youtu.be/rhpJIz6R6mU In the fight against disease, we're vastly outnumbered. The number of bacterial cells and their genetic material far outnumber human cells and genes. ...
Looking back at Angelina Jolie's very public announcement of her elective double mastectomy, we feel that now is a good time to remember ...
Angelina Jolie made worldwide news when she recently revealed her elective double mastectomy as a preventative measure against breast cancer. Experts from Mayo ...
Mayo Clinic is the destination for patients seeking answers, and continues its pursuit for answers with the public launch of its Individualized Medicine Clinic at ...
http://www.youtube.com/watch?v=ugXUFHRZti8&list=PLE4A384A799EFD6C4&index=2 A big week for Mayo Clinic and Individualized Medicine. Mayo Clinic and Cancer Genetics Inc. have teamed teamed up to launch OncoSpire Genomics, a joint ...
Michaela Banck, M.D., Mayo Clinic oncologist and first author of study A new understanding of the genomics behind small intestine neuroendocrine tumors shows promise ...
Individualizing Medicine 2013: From Promise to Practice focuses on how to translate the promise of genomic medicine to your practice. Expert ...